GARS1 and Charcot-Marie-Tooth disease: Thus, although CMT-causing heterozygous mutations in the glycyl-tRNA synthetase gene GARS affect protein synthesis, loss of aminoacylation activity is neither necessary nor sufficient to cause the disease (3–5,7).